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Increased intake of dietary polyunsaturated fat does not promote whole body or
preferential abdominal fat mass loss in overweight adults
Abstract
Objective: There is evidence that increasing the proportion of polyunsaturated fatty acids (PUFA) in a diet
can enhance the rate of fat oxidation acutely. Higher PUFA in a diet has also been associated with greater
abdominal fat loss in longer term studies. This study aimed to investigate if higher PUFA intake would
result in greater fat mass loss over a 12-week period, mainly from the abdominal region.
Methods: Data at the 12-week time point from two weight loss studies, both comparing high PUFA versus
low PUFA diets was, accessed for 141 overweight subjects from the same area. Specifically, data on
anthropometric measurements (weight, height, BMI, body composition, waist and hip circumference, SAT,
VAT) and dietary intake were analyzed. The relationship between fat mass and VAT changes was
examined using a differential equation.
Results: Energy consumption decreased significantly in both study groups. The low fat groups decreased
total dietary fat while the HPUFA groups increased PUFA intake significantly. All anthropometric
measurements reduced significantly over time but there was no difference between the two dietary
groups. The relationship between fat mass and visceral adipose tissue (VAT) loss was allometric.
Conclusion: A higher PUFA intake did not lead to greater fat mass loss and there was no additional
preferential loss of VAT following higher PUFA consumption.
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Increased Intake of Dietary Polyunsaturated Fat
Does Not Promote Whole Body or Preferential
Abdominal Fat Mass Loss in Overweight Adults
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c
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Summary
Objective: There is evidence that increasing the proportion of polyunsaturated fatty acids (PUFA) in a diet can
enhance the rate of fat oxidation acutely. Higher PUFA
in a diet has also been associated with greater abdominal fat loss in longer term studies. This study aimed to
investigate if higher PUFA intake would result in greater
fat mass loss over a 12-week period, mainly from the
abdominal region. Methods: Data at the 12-week time
point from two weight loss studies, both comparing high
PUFA versus low PUFA diets was, accessed for 141 overweight subjects from the same area. Specifically, data
on anthropometric measurements (weight, height, BMI,
body composition, waist and hip circumference, SAT,
VAT) and dietary intake were analyzed. The relationship
between fat mass and VAT changes was examined using
a differential equation. Results: Energy consumption
decreased significantly in both study groups. The low
fat groups decreased total dietary fat while the HPUFA
groups increased PUFA intake significantly. All anthropometric measurements reduced significantly over time
but there was no difference between the two dietary
groups. The relationship between fat mass and visceral
adipose tissue (VAT) loss was allometric. Conclusion:
A higher PUFA intake did not lead to greater fat mass
loss and there was no additional preferential loss of VAT
following higher PUFA consumption.
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Introduction
Dietary fats are high in energy density [1], are the least preferred source of energy during fuel selection by the body
[2, 3], and are oxidized inefficiently during overfeeding [4, 5].
For these reasons they have been implicated in the etiology of
the worldwide obesity epidemic. However, fats are crucial in
maintaining some physiological functions such as maintaining
cell structure and transportation of fat-soluble vitamins [6]. In
addition, to fully eliminate fat from the diet is not possible as
we consume whole foods which come from food sources containing various nutrients in different proportions. Therefore,
it is advisable to recommend restricting dietary fat intake to a
sensible level and at the same time include optimal fats within
a recommended level of intake.
Not all dietary fats have the same physiological functions,
and there is evidence that different fat subtypes are oxidized
in a hierarchy in the human body, depending on their chemical structures. The carbon chain length [7, 8] and degree of
saturation [7] of fatty acids determine both the rate and order
in which fats are oxidized. In humans, this order is polyunsaturated fatty acids (linolenate 18:3n-3; PUFA) first, followed
by monounsaturated fatty acids (oleate 18:1n-9; MUFA), and
saturated fatty acids (stearate 18:0; SFA) last [9]. At a cellular
level, PUFA has been observed to play a role in repartitioning
metabolic fuels for storage and oxidation by down-regulating
the transcription of lipogenic genes and up-regulating the
genes that promote lipid oxidation and thermogenesis [10].
Indeed, in a whole of diet context [11, 12], studies have confirmed a greater fat-oxidizing effect acutely when the ratio of
PUFA:SFA increases. Supplementation of the diet using fish
oil (PUFA rich) has also been shown to increase fat oxidation
[13, 14]. Greater fat oxidation implies a lower retention in the
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Table 1. Study arms of Trial A and Trial B studies
Trial A
Low PUFA

High PUFA

Low PUFA and low energy

High PUFA & low energy

Isocaloric low-fat diet with 20%
protein, 50% CHO, 30% fat (5%
PUFA, 15% MUFA, 10% SFA).

Isocaloric low-fat high PUFA
diet with 20% protein, 50%
CHO, 30% fat (10% PUFA,
10% MUFA, 10% SFA).

A diet similar to the low fat diet
but with a 500 kcal/d energy
deficit.

A diet similar to the high PUFA
diet but with a 500 kcal/d energy
deficit.

Trial B
Low PUFA

High PUFA

Isocaloric low-fat diet with 20% protein, 50% CHO, 30% fat
(5% PUFA, 15% MUFA, 10%SFA). This study arm is the equivalent
of the low fat arm in Trial A.

Isocaloric low-fat high PUFA diet with 20% protein, 50% CHO,
30% fat (10% PUFA, 10% MUFA, 10% SFA). This study arm is the
equivalent of the high PUFA arm in Trial A.

CHO = Carbohydrate; PUFA = polyunsaturated fat; MUFA = monounsaturated fat; SFA = saturated fat.

randomized controlled trial with four study arms while Trial B was a
52-week randomized controlled trial with two study arms. The study arms
are summarized in table 1.
Participants from both trials were recruited from the local community
through media advertisement. Eligible participants attended a pre-study
assessment session where anthropometric measurements, blood biochemistry, habitual dietary intake, and physical activity were assessed. In both
trials, participants randomized into the high PUFA arms received structured dietary advice to incorporate PUFA-rich foods to achieve PUFA target of 10% energy. The intervention group in Trial B also received a daily
supplement of 30 g walnuts. All participants received monthly supports
from qualified dietitians to help adhere to the prescribed diets for the first
12 weeks. After the 12-week period, participants from Trial B attended
quarterly follow-up sessions. The experiment protocols from both trials
were approved by the University of Wollongong Human Research Ethics
Committee and were registered with the Australian Clinical Trial Registry
(Trial A: ACTRN12608000453381; Trial B: ACTRN12607000600448)
Participants
Inclusion criteria for Trial A [20] and Trial B [21] were age > 18 years and
BMI > 25 kgm-2 (participants of both sexes were included); Trial B also
included individuals who were diagnosed with type 2 diabetes (without
insulin treatment). Participants were excluded if they have major illness,
were smokers, allergic to factors inhibiting the trials, illiterate, or showed
inadequate conversational English as dietary counseling was the key component of the intervention. Eligible participants were randomized into
one of the study arms using random permuted blocks by a computerized
random number generator. 20 participants were required in each arm to
provide a power of 80% in order to detect a change of 20% in VAT, as
reported by a previous study [15].

Experimental Protocol
Two dietary interventions (Trial A [20] and Trial B [21]) from which data
was extracted had similar experimental protocols. The key intervention
for both trials was increased dietary PUFA intake. Trial A was a 12-week

Dietary Prescriptions and Physical Activity Recommendations
Dietary recommendations for both Trial A and Trial B were based on
core food groups to meet the target dietary nutrient composition profile
of the different test diets. All participants received individualized [20, 21]
dietary counseling and had the same amount of contact (monthly) with
qualified dietitians for the first 12 weeks of the studies. Participants in the
high PUFA (HPUFA) arms were asked to include PUFA-rich foods in
Trial A while participants in Trial B received a daily supply of walnuts
(30 g/day) to help achieve PUFA target. Compliance to walnut consumption was confirmed through the significant increase in erythrocyte membrane _-linoleic acid in the HPUFA group from baseline to 12 weeks [21].
Participants were also advised to maintain 5 × 30-min physical activity per
week.

Polyunsaturated Fat and Fat Mass Loss
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body. This differential effect of fat subtypes means that the
incorporation of PUFA into a diet may be beneficial in the
promotion of negative fat balance and leads to the use of
endogenous fat as energy source. It may be an important consideration in weight management where adipose tissue accumulation is integral to the problem.
Nonetheless, these observations were obtained from studies using an acute feeding design, and it remains unclear if an
enhanced fat oxidation rate can be extended over a longer
period of time in a free-living environment. The intriguing
question is whether or not the increased fat oxidation rate is
sufficient to induce a state of negative fat balance and cumulatively lead to greater fat mass (FM) loss in overweight individuals. Studies including a higher PUFA intake have been
associated with a greater FM loss in the abdominal region
when the intake of PUFA was increased [15, 16]. This is beneficial to overweight individuals as a greater reduction in abdominal FM will lead to improved metabolic fitness and reduced risks of metabolic disease [17, 18]. This is particularly
the case if the loss of FM comes from the visceral adipose tissues (VAT). Hallgreen and Hall [19] analyzed data from
weight loss trials that employed various methods (calorie restriction, exercise, and surgery) and found no preferential loss
of VAT induced by any of the three methods or their combinations. They concluded that VAT loss is therefore proportionate to the amount of total body FM loss. However, studies
using high PUFA diets were not included in their analysis.
Therefore, this study aimed to investigate if a higher PUFA
intake would result in greater FM loss in the short term,
mainly from the abdominal region.

Table 2. Mean (± SD) anthropometric measurements and dietary intakes at baseline and after 12 weeks
Baseline
LPUFA
(n = 70)
Weight, kg
BMI, kg/m2
Body fat, %
Waist, cm
VAT area, cm2
SAT area, cm2
EI, kcal/day
CHO, %EI
Protein, %EI
Fat, %EI
SFA, %EI
MUFA, %EI
PUFA, %EI

12 weeks
HPUFA
(n = 71)

LPUFA
(n = 70)

HPUFA
(n = 71)

Time
effects
p

Diet
effects
p

Time
× diet effects
p

90.8 ± 14.8
32.1 ± 4.0
39.2 ± 6.6
97.7 ± 12.4
156 ± 91
312 ± 102

88.4 ± 13.9
31.4 ± 3.9
39.4 ± 7.0
96.6 ± 12.5
141 ± 81
338 ± 107

85.1 ± 13.7
30.2 ± 4.0
35.8 ± 7.0
93.2 ± 11.5
130 ± 78
302 ± 108

84.0 ± 14.7
29.9 ± 4.4
37.1 ± 8.3
93.4 ± 13.5
131 ± 90
316 ± 113

0.000*
0.000*
0.000*
0.000*
0.000*
0.001*

0.464
0.463
0.799
0.538
0.606
0.198

0.859
0.844
0.177
0.387
0.052
0.179

2,181 ± 694
42.0 ± 7.0
20.3 ± 3.6
31.7 ± 6.1
10.9 ± 2.9
12.3 ± 3.1
5.5 ± 2.1

2,270 ± 744
43.8 ± 8.7
19.7 ± 3.7
31.7 ± 7.2
11.2 ± 2.7
12.4 ± 4.3
5.1 ± 2.0

1,754 ± 514
44.1 ± 6.7
21.9 ± 3.7
27.7 ± 5.9
9.0 ± 2.2
8.0 ± 4.0
5.4 ± 2.0

1,840 ± 483
43.1 ± 6.3
21.0 ± 3.5
30.9 ± 5.9
8.0 ± 2.2
7.6 ± 3.8
10.2 ± 3.6

0.000*
0.046*
0.000*
0.000*
0.000*
0.000*
0.000*

0.243
0.804
0.066
0.018*
0.470
0.909
0.000*

0.639
0.035*
0.957
0.066
0.003*
0.242
0.000*

LPUFA = Low PUFA group; HPUFA = high PUFA group ; VAT = visceral adipose tissue; SAT = subcutaneous adipose tissue; EI = energy intake;
CHO = carbohydrate; PUFA = polyunsaturated fat; MUFA = monounsaturated fat; SFA = saturated fat.
*Significant different, general linear model repeated measures ANOVA, p < 0.05.

Body Weight and Body Composition
Body weight was measured, and percentage body fat was estimated using
scales with bioelectrical impedance (Tanita TBF622; Tanita Corp.,
Tokyo, Japan) in an upright position with minimal clothing. Body fat
measurements from this device have been previously shown to be comparable to those from the DEXA scans [22]. Single-slice abdominal computed tomography (CT) scans were also taken at the fourth and fifth
lumbar vertebra (L4–L5), as well as at the level of sacroiliac joints by a
trained observer at a commercial X-ray facility in Wollongong (Southcoast X-Ray, NSW, Australia). Subcutaneous adipose tissue (SAT) and
VAT areas at L4–L5 levels were estimated using SIENET Sky software
(Siemens AG, Munich, Germany), and the mean of these two levels were
calculated. Using the mean VAT areas (AVAT), total volume of VAT
(VVAT) at the abdominal region was estimated using the equations
described by Shen and colleagues [23]:
Men: VVAT = 0.0224 × AVAT + 0.162 l
Women: VVAT = 0.0205 × AVAT + 0.147 l

(1)
(2)

Relationship between FM and VAT Loss
To examine if there is preferential loss of VAT, its changes will be examined alongside total FM loss using the mathematical model described by
Hallgreen and Hall [19], which was an extension to the observations by
the original works by Smith and Zachwieja [24]. It was hypothesized that
FM and VAT changes follow an allometric relationship as shown by the
differential equation below:
VAT/FM = k × dVAT/dFM

(3)

where VAT and FM refer to initial (before treatment) VAT and FM;
dVAT and dFM refer to changes in VAT and FM over time; and k is the
dimensionless constant which can be calculated from the other 4 known
variables.
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Dietary Intake
Habitual dietary intake was assessed using a validated diet history interview [25] conducted by dietitians and a 3-day food record. Dietary composition was analyzed using the FoodWorks nutrient analysis software
package (Xyris Software, Professional Version 2002, Brisbane, Australia). Fatty acid intake profiles were obtained using the AUSNUT
fatty acid database (Version 6, 2002) in the FoodWorks software package and the Australian Fatty Acids Rev 6 2002 (RMIT, Melbourne,
Australia).

Data Analysis
For the purpose of this paper, only data collected at baseline and 12
weeks was included. Data from Trial A and Trial B were combined in
order to test the relationship between FM and VAT changes. The study
arms in both studies were collapsed into low fat (LPUFA) and HPUFA
groups for comparison purposes. Data was analyzed using SPSS statistical
software (version 15.0.0, SPSS, Chicago, IL, USA). Baseline differences
between diet groups were assessed using one-way ANOVA, with post
hoc comparisons using a Bonferroni adjustment. Changes in the primary
outcomes between LPUFA and HPUFA were compared using the
general linear model for repeated measures ANOVA.

Results
Participants
From both Trial A and Trial B, 273 participants were
screened, where 200 were eligible and enrolled. They were
randomly assigned to one of the study arms. 28 volunteers
withdrew prior to the commencement of the studies (Trial A,
n = 18; Trial B, n = 10), and 31 were lost to follow-up visits
(Trial A, n = 11; Trial B, n = 20). Of the original 200 participants, 141 completed the studies. Data from 121 out of the
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Measurements

Table 3. Characteristics of participants (N = 121) at baseline and 12-week of study
Baseline

Age, years
Weight, kg
BMI, kg/m2
FM, kg
FFM, kg
VVAT, l

12 weeks

LPUFA
(n = 58)

HPUFA
(n = 63)

LPUFA
(n = 58)

HPUFA
(n = 63)

48.4 ± 10.6
88.0 ± 13.7
31.3 ± 3.8
33.6 ± 8.2
54.4 ± 9.9
3.5 ± 2.0

47.6 ± 10.5
87.2 ± 14.0
31.0 ± 4.0
33.9 ± 9.0
53.3 ± 10.3
3.2 ± 1.8

–
84.7 ± 13.7
30.1 ± 4.0
30.6 ± 8.2
54.1 ± 10.2
2.9 ± 1.7

–
83.7 ± 14.6
29.8 ± 4.4
31.3 ± 9.7
52.4 ± 10.4
2.9 ± 2.0

Time
effects
p

Diet
effects
p

Time
× diet effects
p

–
0.000*
0.000*
0.000*
0.000*
0.000*

–
0.721
0.657
0.753
0.449
0.628

–
0.803
0.791
0.376
0.023*
0.065

LPUFA = Low PUFA group; HPUFA = high PUFA group; FM = fat mass; FFM = fat-free mass; VAT = visceral adipose tissue.
*Significant different, general linear model repeated measures ANOVA.

Dietary Change
Dietary intervention effect was achieved in Trial A and Trial
B. The combined analysis for the purpose of this paper shows
that the intakes of energy and macronutrients changed significantly within each study group (table 2) after the 12-week
intervention period. Of all macronutrients, only the percentages of total fat (diet, p = 0.018) and PUFA (diet, p < 0.001)
were significantly different between groups, where the
LPUFA group reduced fat intake and the HPUFA group increased PUFA consumption. The interaction effects were significant for carbohydrate (p = 0.035), SFA (p = 0.003) and
PUFA (p < 0.001) proportions in the diets. The LPUFA
group increased the proportion of carbohydrate to substitute
dietary fat while the HPUFA group increased their PUFA
intake at the expense of SFA in the diet.

complete data sets containing FM and VAT volume from
Trial A and Trial B were analyzed. Baseline and post-intervention (12-week) measurements of weight, BMI, FM, fatfree mass (FFM), and VAT volume are presented in table 3.
FM and volume of VAT decreased significantly in both
groups after the 12-week period, but there was no difference between LPUFA and HPUFA groups. The dimensionless constant was k = 1.15 ± 3.59 for the LPUFA group
and k = 1.23 ± 2.86 for the HPUFA group, and they were
not significantly different between groups (independent
sample t-test, p = 0.896).

Discussion

Relationship between FM and VAT Changes
To test if the relationship between the changes of these two
variables was allometric, 121 (58 LPUFA and 63 HPUFA)

This study aimed to investigate the relationship between dietary PUFA intake, FM loss as well as preferential abdominal
FM loss as reported by other studies. Using the data from two
intervention trials, we showed that the enhanced fat oxidation
by PUFA observed in acute studies failed to produce greater
FM loss using a longitudinal study design. Previous studies
reported abdominal fat loss and total FM loss independently;
when we examined them together, preferential loss of abdominal fat following increased PUFA intake was not observed.
There were some limitations to this study. It included convenient samples obtained from two separate clinical trials that
utilized different dietary strategies. However, the treatments
and study protocols were similar (high vs. low PUFA intake),
and the clinical outcomes were not likely to be confounded by
these differences. This study compared data between baseline
and 12 weeks only, making the comparison over a longer period of time impossible. This was due to the length of original
study (Trial A), but 3-month changes in weight and body
composition are still of clinical importance. There was also
concern over the PUFA consumptions in both study groups,
where some participants in LPUFA group consumed higher

Polyunsaturated Fat and Fat Mass Loss
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Anthropometric Change
Weight change was significant in the original studies (Trial A
and Trial B), and when data was combined and analyzed in
this study, all groups also lost weight significantly after the
12-week period. Subsequently, all other parameters were
significantly reduced over time (time, p ≤ 0.001). However,
these changes were not different between the LPUFA and
HPUFA groups, and interaction effects were also not observed (table 2).
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141 subjects was included because CT scans at both time
points were available. 20 subjects did not have the CT scan
done at 12 weeks of the studies, and data from these subjects
were excluded. Baseline characteristics and habitual intake of
these participants were not statistically different (p > 0.05)
(table 2).
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in a free-living environment. These are the areas that warrant
further investigation.
Changes in FM in our analysis follow a similar trend to
weight loss with a significant FM loss over time, but no diet
effect was observed. Although there is indication that higher
PUFA consumption acutely enhanced fat oxidation [9], our
data suggests that this acute effect could not be translated
into weight loss in the longer term in a free-living environment. Our observation is not consistent with the results of a
study by Couet and colleagues [14] who found significantly
greater FM loss over a 3-week period. This may be due to the
differences in a few aspects of the study. Overweight participants in our study may have different fat oxidation rates to
the lean subjects in study by Couet et al. [28], where overweight individuals have been shown to have blunted lipid
oxidation. The difference in the length of study and the use of
supplements and how they are digested and metabolized may
impact on the compliance to the treatment. At this stage, the
effects of adaptations of the human body to increased dietary
PUFA remains unclear.There was a significant interaction
effect of treatment on FFM changes in our study, where
the HPUFA group lost more FFM than the LPUFA group
(–0.3 kg/12 weeks vs. –0.9 kg/12 weeks). The significant
change in FFM was a novel observation because limited studies have compared the effectiveness of high versus low PUFA
diets in promoting weight and FM loss. From a mechanistic
perspective, it may be speculated that higher PUFA intake
increases skeletal muscle membrane PUFA composition,
which has been reported to be inversely correlated with fasting insulin level [29]. Indeed, a significantly greater decrease
in fasting insulin in the HPUFA group was observed in Trial
B [21]. Insulin is an anabolic hormone, and its decrease related to increased PUFA intake may have contributed to the
greater FFM loss in the HPUFA arm in this study. Further
investigations are required to explain such observation since
empirical data to support this speculation is lacking.
The current analysis did not demonstrate additional benefits of a HPUFA diet on abdominal fat loss. This was evident
from the similar changes in SAT and VAT areas in both
study groups. When VAT area was converted into VAT volume, changes in VAT were again not significantly different
between groups. The mean k values, calculated using equation (3), as outlined in the methods section, were very close
to those reported by Hallgreen and Hall [19], where studies
using energy restriction alone produced a mean value of
k = 1.2 while combined strategies involving energy restriction
and resistance exercise produced k = 1.3. Effects of LPUFA
diet in this study generated a k value close to energy restriction (mean k = 1.15), while k of HPUFA fell between
energy restriction with and without resistance exercise (mean
k = 1.23). Nonetheless, dimensionless constant k was not different between LPUFA and HPUFA groups, implying that
there is preferential loss of VAT (k > 1), but it was not different from VAT loss induced by other weight loss strategies.
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PUFA while some in the HPUFA group consumed low
PUFA during the data collection period. When we performed
head-to-head comparison, the change in PUFA intake and
FM (0–12 weeks) did not correlate for all participants (r =
0.076, p = 0.409). It turns out that this analysis further supports and strengthens our observation that changing PUFA
intake may have limited impact on body FM. Physical activity
was not measured during the intervention period, and it was
uncertain if this has changed. Precautions were taken in the
original trials where participants were told to maintain 30-min
exercise five times a week, and this was emphasized by the
dietitians on a monthly basis.
This study also has a number of strengths. First, it examines the possibilities of acute metabolic effects of increased
PUFA intake observed in a controlled laboratory setting be
extended into a less-restrictive free-living environment over a
12-week period. This is crucial in demonstrating the effectiveness and practicality of a weight management strategy. Another strength of this study is that it differs from the previous
studies in that it compares the change in visceral fat relative to
the total fat change, not in isolation. Pooling data from our
two previous studies that originally addressed other specific
study outcomes provided us with a greater sample size to examine this issue. This study points out errors in conclusions
that can be drawn if FM and VAT are considered independently. For example, although the between-groups differences
in VAT area and volume were approaching statistical significance (p = 0.052 and p = 0.065, respectively), they diminished
(p = 0.896) when examined as a ratio to total FM change.
The failure to replicate the results from previous studies
was not likely to be confounded by the dietary compliance in
this study, where dietary effects were reported in the original
trials, and the combined data. Diet history analyses showed
that the HPUFA groups increased their PUFA proportion in
the diet while the LPUFA groups did not change their PUFA
consumption after 12 weeks, indicating effective and successful execution of dietary interventions. One can increase the
intake of PUFA by substituting SFA either through careful
dietary modeling to identify and incorporate PUFA-rich
foods into the diet or by supplementing with foods like
walnuts.
This study was motivated by previous research that reported a higher thermogenic effect of PUFA in the short
term, where the basal metabolic rate and thermic effect of
food were observed to elevate following meals with higher
PUFA content [26, 27]. However, this was not reflected in our
study as the weight loss of participants in the HPUFA group
was not higher than that in the LPUFA group, although both
groups lost weight significantly over the 12-week study period. Weight loss is likely to largely result from the significantly lower energy intake after 12 weeks as shown in table 2.
This implies that either the elevated thermogenesis was not
great enough to produce a significantly greater weight loss or
the thermogenic effect of HPUFA diets has been washed out

Conclusion
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Energy restriction produced greater weight loss with or without increasing PUFA in the diet. The HPUFA diet failed to
produce greater FM loss despite greater fat oxidation rates
observed in other acute feeding trials. The dimensionless constant, k, was also not different, implying that there was no
preferential fat oxidation in the abdominal region from the
higher PUFA intake. This study suggests that the loss of VAT
depends on the total loss of body FM and is minimally influenced by the PUFA in the diet.
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